Cite
HARVARD Citation
Hoffmann‐Vold, A. et al. (2018). CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis. Arthritis & rheumatology. 70 (10), pp. 1644-1653. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hoffmann‐Vold, A. et al. (2018). CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis. Arthritis & rheumatology. 70 (10), pp. 1644-1653. [Online].